SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

4.

Virtual Reality Travel Reduces Cancer Pain.

5.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot